文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Gastro-oesophageal reflux disease (GORD) in Australian general practice patients.

作者信息

Miller Graeme, Wong Carmen, Pollack Allan

机构信息

MBBS, PhD, FRACGP, Associate Professor and Medical Director, Family Medicine Research Centre, University of Sydney, Parramatta, NSW.

出版信息

Aust Fam Physician. 2015 Oct;44(10):701-4.

DOI:
PMID:26484482
Abstract

Gastro-oesophageal reflux disease (GORD) imposes a high level of societal and financial burden on the community. Recently, concern has been expressed regarding the number of prescriptions for proton pump inhibitors (PPIs), mostly for GORD, in Australia. This study investigated changes in the management of GORD since 2006–08. This was a secondary analysis of data from the Bettering the Evaluation and Care of Health (BEACH) program. There was an increase of about 15% in the management rate of GORD between 2006–08 and 2012–14. Medication rates were high, with 95 prescriptions per 100 GORD problems managed, of which 83% were for PPIs. Most patients with GORD are on long-term PPI therapy, usually at full dosage. Trials of cessation or dosage reduction may be appropriate in many patients.

摘要

相似文献

[1]
Gastro-oesophageal reflux disease (GORD) in Australian general practice patients.

Aust Fam Physician. 2015-10

[2]
Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.

Eur J Gastroenterol Hepatol. 2013-1

[3]
Acid suppressants for managing gastro-oesophageal reflux and gastro-oesophageal reflux disease in infants: a national survey.

Arch Dis Child. 2018-2-22

[4]
GORD.

Aust Fam Physician. 2009-12

[5]
Associations between gastro-oesophageal reflux, its management and exacerbations of chronic obstructive pulmonary disease.

Respir Med. 2015-9

[6]
Pharmacological management of gastro-oesophageal reflux disease.

Drugs. 1995-5

[7]
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

Cochrane Database Syst Rev. 2006-7-19

[8]
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

Cochrane Database Syst Rev. 2010-11-10

[9]
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

Cochrane Database Syst Rev. 2000

[10]
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.

Cochrane Database Syst Rev. 2013-5-31

引用本文的文献

[1]
Assessment of laparoscopic fundoplication with endoscopy: room for improvement.

Surg Endosc. 2024-2

[2]
Laparoscopic fundoplication versus laparoscopic Roux-en-Y gastric bypass for gastro-oesophageal reflux disease in obese patients: protocol for a randomized clinical trial.

BJS Open. 2022-11-2

[3]
Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study.

Nutrients. 2020-6-18

[4]
Health status and healthcare trends of individuals accessing Australian aged care programmes over a decade: the Registry of Senior Australians historical cohort.

Intern Med J. 2021-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索